182 related articles for article (PubMed ID: 16406448)
1. Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization.
Cirri M; Maestrelli F; Corti G; Furlanetto S; Mura P
J Pharm Biomed Anal; 2006 Sep; 42(1):126-31. PubMed ID: 16406448
[TBL] [Abstract][Full Text] [Related]
2. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
Faucci MT; Mura P
Drug Dev Ind Pharm; 2001 Oct; 27(9):909-17. PubMed ID: 11763468
[TBL] [Abstract][Full Text] [Related]
3. Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state.
Mura P; Furlanetto S; Cirri M; Maestrelli F; Corti G; Pinzauti S
J Pharm Biomed Anal; 2005 Apr; 37(5):987-94. PubMed ID: 15862677
[TBL] [Abstract][Full Text] [Related]
4. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation.
Pathak SM; Musmade P; Dengle S; Karthik A; Bhat K; Udupa N
Eur J Pharm Sci; 2010 Nov; 41(3-4):440-51. PubMed ID: 20656025
[TBL] [Abstract][Full Text] [Related]
5. Solubilization of a naphthoquinone derivative by hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and polyvinylpyrrolidone (PVP-K30). The influence of PVP-K30 and pH on solubilizing effect of HP-beta-CD.
Granero G; de Bertorello MM; Longhi M
Boll Chim Farm; 2002; 141(1):63-6. PubMed ID: 12064060
[TBL] [Abstract][Full Text] [Related]
6. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
[TBL] [Abstract][Full Text] [Related]
7. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
[TBL] [Abstract][Full Text] [Related]
8. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.
Mura P; Bettinetti GP; Cirri M; Maestrelli F; Sorrenti M; Catenacci L
Eur J Pharm Biopharm; 2005 Jan; 59(1):99-106. PubMed ID: 15567306
[TBL] [Abstract][Full Text] [Related]
9. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
[TBL] [Abstract][Full Text] [Related]
10. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
11. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Aug; 320(1-2):53-7. PubMed ID: 16701974
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin.
Tommasini S; Calabrò ML; Raneri D; Ficarra P; Ficarra R
J Pharm Biomed Anal; 2004 Oct; 36(2):327-33. PubMed ID: 15496325
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin solubilization of ETH-615, a zwitterionic drug.
Loftsson T; Petersen DS
Drug Dev Ind Pharm; 1998 Apr; 24(4):365-70. PubMed ID: 9876597
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
Pescitelli G; Bilia AR; Bergonzi MC; Vincieri FF; Di Bari L
J Pharm Biomed Anal; 2010 Aug; 52(4):479-83. PubMed ID: 20185265
[TBL] [Abstract][Full Text] [Related]
15. Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
Li J; Xiao H; Li J; Zhong Y
Int J Pharm; 2004 Jul; 278(2):329-42. PubMed ID: 15196638
[TBL] [Abstract][Full Text] [Related]
16. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.
Wu WM; Wu J; Bodor N
Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin-enhanced solubilization of pentachlorophenol in water.
Hanna K; de Brauer Ch; Germain P
J Environ Manage; 2004 May; 71(1):1-8. PubMed ID: 15084354
[TBL] [Abstract][Full Text] [Related]
18. [Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
Kopecký F; Kopecká B
Ceska Slov Farm; 2005 May; 54(3):137-40. PubMed ID: 15945461
[TBL] [Abstract][Full Text] [Related]
19. Ternary systems of naproxen with hydroxypropyl-beta-cyclodextrin and aminoacids.
Mura P; Maestrelli F; Cirri M
Int J Pharm; 2003 Jul; 260(2):293-302. PubMed ID: 12842348
[TBL] [Abstract][Full Text] [Related]
20. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
